CrossrefInfokarte
KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation
Hypoxia · 2017
DOI: 10.2147/hp.s132832 ↗Abstract
Kein Abstract verfügbar.
EUVIMED